<?xml version="1.0" encoding="UTF-8"?>
<p id="par0035">Although all human CoVs are a real threat to human populations, numerous researches have mainly been focused on SARS- and MERS-CoVs infections. Because they were responsible for severe illness when compared to other CoVs. Numerous agents have been identified to inhibit the entry and/or replication of SARS- and MERS-CoVs in cell culture or animal models 
 <xref rid="bib0205" ref-type="bibr">41</xref>, 
 <xref rid="bib0210" ref-type="bibr">42</xref>. Due to the high morbidity and mortality rates of SARS and MERS, several antiviral drugs and immunomodulators have been used empirically or evaluated in uncontrolled trials 
 <xref rid="bib0205" ref-type="bibr">41</xref>, 
 <xref rid="bib0215" ref-type="bibr">43</xref>, 
 <xref rid="bib0220" ref-type="bibr">44</xref>, 
 <xref rid="bib0225" ref-type="bibr">45</xref>, 
 <xref rid="bib0230" ref-type="bibr">46</xref>, 
 <xref rid="bib0235" ref-type="bibr">47</xref>, 
 <xref rid="bib0240" ref-type="bibr">48</xref>, 
 <xref rid="bib0245" ref-type="bibr">49</xref>, 
 <xref rid="bib0250" ref-type="bibr">50</xref>, 
 <xref rid="bib0255" ref-type="bibr">51</xref>, 
 <xref rid="bib0260" ref-type="bibr">52</xref>, 
 <xref rid="bib0265" ref-type="bibr">53</xref> (see for representative examples 1â€“6 in 
 <xref rid="fig0015" ref-type="fig">Fig. 3</xref> ).
</p>
